If the two sides continue to fail to reach an agreement, the union will begin collective action on May 21, followed by a full general strike on May 1, ...

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.#SamsungBiologics #strike #laborunion #CDMO #biopharmaceutical #collectivebargaining #wagenegotiation #SamsungGroup
Samsung Biologics Faces First Strike in 15-Year History

Samsung Biologics Faces First Strike in 15-Year History

Samsung Biologics faces its first strike since founding as 95.5% of union voters back walkout, threatening the company's 15 trillion won CDMO expansion strategy amid global competition.

Seoul Economic Daily

The union plans, should the vote approve strike action, to begin collective action on May 21 and escalate to a full-scale general strike on May 1, ...

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.#SamsungBiologics #laborstrike #wagenegotiations #CDMO #biopharmaceutical #unionvote #SamsungGroup #collectivebargaining
Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

Samsung Biologics Faces First-Ever Strike as 95% of Union Members Vote

Samsung Biologics faces its first-ever strike as union members overwhelmingly vote on industrial action after 13 rounds of failed wage negotiations, with workers demanding 14% pay raises amid record earnings.

Seoul Economic Daily
Alteogen Inc. reported a 275% year-on-year surge in 2023 operating profit to 1.148 trillion won, with revenue more than doubling, reflecting robust growth in South Korea's biopharmaceutical sector.
#YonhapInfomax #Alteogen #OperatingProfit #Revenue #Biopharmaceutical #YearOnYearGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103316
Alteogen Posts 275% Surge in 2023 Operating Profit to 114.8 Billion Won

Alteogen Inc. reported a 275% year-on-year surge in 2023 operating profit to 1.148 trillion won, with revenue more than doubling, reflecting robust growth in South Korea's biopharmaceutical sector.

Yonhap Infomax
Alteogen, a South Korean biopharmaceutical company, reported a 275% year-on-year jump in 2023 operating profit, reaching KRW 114.8 billion.
#YonhapInfomax #Alteogen #OperatingProfit #2023Earnings #Biopharmaceutical #KRW1148Billion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103313
Alteogen Posts 275% Surge in 2023 Operating Profit to KRW 114.8 Billion

Alteogen, a South Korean biopharmaceutical company, reported a 275% year-on-year jump in 2023 operating profit, reaching KRW 114.8 billion.

Yonhap Infomax
Samsung Bioepis Holdings posts Q4 revenue of 251.7 billion won and an operating loss of 63.6 billion won, reflecting ongoing challenges in the biopharmaceutical sector.
#YonhapInfomax #SamsungBioepisHoldings #Q4Revenue #OperatingLoss #Biopharmaceutical #FinancialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102020
Samsung Bioepis Holdings Reports Q4 Revenue of 251.7 Billion Won and Operating Loss of 63.6 Billion Won

Samsung Bioepis Holdings posts Q4 revenue of 251.7 billion won and an operating loss of 63.6 billion won, reflecting ongoing challenges in the biopharmaceutical sector.

Yonhap Infomax
Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.
#YonhapInfomax #KoreaBiomedicineIndustryAssociation #Biopharmaceutical #AIDrugDevelopment #Biosimilars #CDMO #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=97657
Korea Biomedicine Industry Association Chief - 'A Year of Transition and Restructuring—Poised for Leap Forward in the New Year'

Korea Biomedicine Industry Association Chairman Lee Jeong-seok highlighted 2025 as a year of transition and restructuring for the bio industry, projecting significant growth and global competitiveness in the coming year through advances in AI drug development, biosimilars, and CDMO.

Yonhap Infomax
[#TRADESHOW] The 93rd #API #China will be held from November 12–14, 2025, at the #Chongqing #International #Exposition #Center (#CQEXPO). As a #leading #exhibition #event in the #pharmaceutical and #biopharmaceutical #industry, API China #Expo brings together #global and domestic stakeholders for #trade, #networking, and #business #collaboration across the pharmaceutical raw m#aterials and #bioprocessing #sectors. https://cnbusinessforum.com/event/93rd-api-china-2025/
93rd API China 2025 | Chongqing Pharmaceutical Ingredients &

Join The 93rd API China, November 12–14, 2025 in Chongqing. Showcase & source APIs, fine chemicals, biopharma services & pharmaceutical machinery. Register free today to meet industry l

China Business Forum
[#TRADESHOW] The 93rd #API #China will be held from November 12–14, 2025, at the #Chongqing #International #Exposition #Center (#CQEXPO). As a #leading #exhibition #event in the #pharmaceutical and #biopharmaceutical #industry, API China #Expo brings together #global and domestic stakeholders for #trade, #networking, and #business #collaboration across the pharmaceutical raw m#aterials and #bioprocessing #sectors. https://cnbusinessforum.com/event/93rd-api-china-2025/
93rd API China 2025 | Chongqing Pharmaceutical Ingredients &

Join The 93rd API China, November 12–14, 2025 in Chongqing. Showcase & source APIs, fine chemicals, biopharma services & pharmaceutical machinery. Register free today to meet industry l

China Business Forum
[#TRADESHOW] The 93rd #API #China will be held from November 12–14, 2025, at the #Chongqing #International #Exposition #Center (#CQEXPO). As a #leading #exhibition #event in the #pharmaceutical and #biopharmaceutical #industry, API China #Expo brings together #global and domestic stakeholders for #trade, #networking, and #business #collaboration across the pharmaceutical raw m#aterials and #bioprocessing #sectors. https://cnbusinessforum.com/event/93rd-api-china-2025/
93rd API China 2025 | Chongqing Pharmaceutical Ingredients &

Join The 93rd API China, November 12–14, 2025 in Chongqing. Showcase & source APIs, fine chemicals, biopharma services & pharmaceutical machinery. Register free today to meet industry l

China Business Forum
[#TRADESHOW] The 93rd #API #China will be held from November 12–14, 2025, at the #Chongqing #International #Exposition #Center (#CQEXPO). As a #leading #exhibition #event in the #pharmaceutical and #biopharmaceutical #industry, API China #Expo brings together #global and domestic stakeholders for #trade, #networking, and #business #collaboration across the pharmaceutical raw m#aterials and #bioprocessing #sectors. https://cnbusinessforum.com/event/93rd-api-china-2025/
93rd API China 2025 | Chongqing Pharmaceutical Ingredients &

Join The 93rd API China, November 12–14, 2025 in Chongqing. Showcase & source APIs, fine chemicals, biopharma services & pharmaceutical machinery. Register free today to meet industry l

China Business Forum